Compare GME & RGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GME | RGC |
|---|---|---|
| Founded | 1996 | 2014 |
| Country | United States | Hong Kong |
| Employees | N/A | N/A |
| Industry | Electronics Distribution | Medicinal Chemicals and Botanical Products |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.7B | 11.5B |
| IPO Year | 2005 | 2020 |
| Metric | GME | RGC |
|---|---|---|
| Price | $21.94 | $4.81 |
| Analyst Decision | Sell | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $13.50 | N/A |
| AVG Volume (30 Days) | ★ 4.0M | 568.6K |
| Earning Date | 06-09-2026 | 10-31-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 133.33 | N/A |
| EPS | ★ 0.66 | N/A |
| Revenue | ★ $3,629,900,000.00 | N/A |
| Revenue This Year | $18.98 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $33.67 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $19.94 | $4.92 |
| 52 Week High | $28.10 | $69.00 |
| Indicator | GME | RGC |
|---|---|---|
| Relative Strength Index (RSI) | 48.12 | 24.44 |
| Support Level | $21.09 | N/A |
| Resistance Level | $22.02 | $29.26 |
| Average True Range (ATR) | 0.57 | 1.23 |
| MACD | 0.04 | 0.39 |
| Stochastic Oscillator | 43.88 | 1.57 |
GameStop Corp offers games, collectibles, and entertainment products through its stores and ecommerce platforms. Its products include Hardware and accessories offering new and pre-owned gaming platforms from the console manufacturers, Software offering new and pre-owned gaming software for current and certain prior generation consoles and sell a wide range of in-game digital currency, digital downloadable content and full-game downloads, and Collectibles consist of apparel, toys, trading cards, gadgets and other retail products for pop culture and technology enthusiasts and collectibles related services, such as submission services for the authentication and grading of trading cards. The company operates its business in three geographic segments: the United States, Australia, and Europe.
Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.